Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Invested Capital (ROIC) | 0.0% | 0.0% | 0.0% | 1,377.8% | 977.2% | 2,035.5% | 1,658.7% | (35,009.9%) | (13,434.9%) | 4,175.1% | 1,435.2% | 5,042.8% | (44.4%) | (2,250.7%) | (50,412.7%) | (1,011.6%) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is (393.0%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for Aadi Bioscience, Inc. have been (1,254.1%) over the past three years, and 251.6% over the past five years.
As of today, Aadi Bioscience, Inc.'s Return on Invested Capital (ROIC) is (393.0%), which is lower than industry median of (130.0%). It indicates that Aadi Bioscience, Inc.'s Return on Invested Capital (ROIC) is Bad.